MEDPMedpace Holdings, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 18442
Ticker: MEDP
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2016-08-11
Round lot: 40
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MEDP

Detail

Enriched 2026-08-14 20:47

Market cap: $16,662,699,801.9
Shares outstanding (class): 27,911,655
Shares outstanding (weighted): 27,911,655
SIC: 8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees: 6,500
Location: CINCINNATI, OH
Homepage: https://www.medpace.com
Description: Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Market cap and share counts drift.

Funds holding this security

277 funds · 280 positions · $2.72B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Mid-Cap ETF iShares Trust	IJH	$355.70M	0.34%	740,739 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$344.82M	0.02%	718,094 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$251.40M	0.15%	523,537 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$140.72M	0.36%	293,046 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$120.13M	0.15%	250,169 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$81.59M	1.00%	169,922 NS	FIGI
State Street SPDR S&P MidCap 400SM ETF Trust —	—	$81.15M	0.34%	168,988 NS	FIGI
Wasatch Core Growth Fund WASATCH FUNDS TRUST	—	$77.46M	2.60%	161,304 NS	FIGI
iShares Russell Mid-Cap Growth ETF iShares Trust	IWP	$72.08M	0.39%	150,107 NS	FIGI
iShares S&P Mid-Cap 400 Growth ETF iShares Trust	IJK	$65.51M	0.66%	136,428 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 400(TM) M… SPDR SERIES TRUST	SPMD	$52.59M	0.34%	109,517 NS	FIGI
Wasatch Small Cap Growth Fund WASATCH FUNDS TRUST	—	$43.34M	3.59%	90,249 NS	FIGI
iShares Russell 1000 Growth ETF iShares Trust	IWF	$43.22M	0.04%	90,006 NS	FIGI
iShares Russell Mid-Cap ETF iShares Trust	IWR	$41.12M	0.09%	85,634 NS	FIGI
Putnam Small Cap Growth Fund Putnam Funds Trust	—	$40.00M	1.48%	83,300 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMEDP
FIGI_COMPOSITEBBG0065B7K59
FIGI_SHARE_CLASSBBG0065B7K40
CIK0001668397
ISINUS58506Q1094
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Life Sciences Tools
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Medpace is a contract research organization providing drug development services, fitting the life science tools and services category.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.